UC - ULCERATIVE COLITIS
Clinical trials for UC - ULCERATIVE COLITIS explained in plain language.
Never miss a new study
Get alerted when new UC - ULCERATIVE COLITIS trials appear
Sign up with your email to follow new studies for UC - ULCERATIVE COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill could help hospitalized ulcerative colitis patients avoid surgery
Disease control Not yet recruitingThis study tests whether the oral medication upadacitinib can safely treat adults hospitalized with acute severe ulcerative colitis and potentially reduce the need for steroids or surgery. About 50 participants will take upadacitinib daily while in the hospital and be monitored f…
Matched conditions: UC - ULCERATIVE COLITIS
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New ulcerative colitis drug begins first human safety tests
Knowledge-focused Not yet recruitingThis early-stage study tests whether a new drug called LYNC-101 is safe in 50 healthy adults aged 18-60. Participants receive either the drug or a placebo by IV, once or three times over several weeks. The goal is to check for side effects and how the drug moves through the body,…
Matched conditions: UC - ULCERATIVE COLITIS
Phase: PHASE1 • Sponsor: LyncBio Therapeutics Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:09 UTC